Company news

Share this article:
Revolution Health and EmergingMed announced a partnership to offer a new cancer clinical trial matching service for patients and physicians. “EmergingMed is committed to providing personalized services to patients who are exploring treatment options,” said Courtney Hudson, EmergingMed founder and CEO in a statement. “We believe patients should have access to the latest research options targeting their specific diagnoses.” The service is available for online searching, as well as by telephone.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions